News | Aquavit Pharmaceuticals, Inc.

Aquavit files patent for an innovative method for delivering exosomes using microchannel technology

October 15, 2020: New York, NY Aquavit filed a new patent application with the United States Patent and Trademark Office. The patent...

Aquavit Pharmaceuticals, Inc. Wins Default Judgement Against Counterfeiter

September 08, 2020: New York, NY Aquavit Pharmaceuticals, Inc. ("Aquavit") won a default judgement against counterfeiter in the United...

Aquavit Files For New COVID-19 Self-Administrable Vaccine Delivery Method and Technology Patent

August 18, 2020: New York, NY Aquavit Files For New COVID-19 Self-Administrable Vaccine Delivery Method and Technology Patent Through...

Aquavit Pharmaceuticals, Inc. Secures Court Order on Compensatory Sanctions Against Counterfeiters

August 13, 2020: New York, NY Aquavit Pharmaceuticals, Inc. Secures Court Order on Compensatory Sanctions Against Counterfeiters for...

Aquavit files patent for a unique method to treat Macular Degeneration

July 1, 2020; New York, NY Aquavit has filed a new patent application with the United States Patent and Trademark Office. The patent...

Aquavit Unveils Its Platform Technology Addressing COVID-19 at 2020 BIO International Conference

June 08, 2020: New York, NY Aquavit Pharmaceuticals Unveils Its Platform Technology Addressing COVID-19 at 2020 BIO International...

New Drug Delivery Platform and Immunotherapeutic Compositions Against Cancer

April 15, 2020: New York, NY New Drug Delivery Platform and Immunotherapeutic Compositions Against Cancer Using Proprietary Microchannel...

New Drug Delivery Platform and Vaccine Compositions for Immunizing Patients Against COVID-19

March 27, 2020: Aquavit Pharmaceuticals, Inc. Announces Filing of New Patent Applications for a New Drug Delivery Platform and Vaccine...

A Novel Method for detecting Allergic reactions using microchannel delivery Technology

March 27, 2020 Aquavit filed a new patent application with the United States Patent and Trademark Office. The patent covers novel methods...

Aquavit Pharmaceuticals, Inc. Introduces Jill Waibel, MD., New Chief Medical Officer (CMO)

June 3, 2019: New York, NY New York-based Aquavit Pharmaceuticals, Inc. is delighted to introduce Dr. Jill Waibel as its new Chief...

Chief Executive Officer Sobin Chang Presenting at World-Renowned BIO International Convention

June 3, 2019: New York, NY Aquavit Pharmaceuticals, Inc. announced today that Chief Executive Officer Sobin Chang will be presenting at...

Police Requests Indictment of U-BioMed and CEO Nyunshik Eum for Trademark Infringement & Counterfeit

Seoul, South Korea May 28, 2019 – Aquavit Life Sciences, Inc. today received an official notice from the police that they have requested...

Preliminary Injunction Order Against Counterfeiters on Patent and Trademark Infringement Case

NEW YORK, April 29, 2019 – Aquavit Pharmaceuticals, Inc. secured a Preliminary Injunction Order in the United States District Court for...

ALERT AQUAGOLD® fine touch™ COUNTERFEIT

March 4, 2019 Dear Valued Customers: It has come to our attention that an illegal Korean operator has been falsely advertising as if they...

Aquavit Life Sciences, Inc. Announces Acquisition Of Manufacturer Hail Co. Ltd.

SEOUL, Nov.13, 2017 / South Korea/ — Aquavit Life Sciences, Inc. (Aquavit) is pleased to announce the acquisition of Korean manufacturing...

Aquavit Pharmaceuticals Adds New Patent To Its High-Tech Medical Portfolio

New York, NEW YORK, September 1, 2017 Aquavit Pharmaceuticals, Inc. announced that the United States Patent and Trademark Office (USPTO)...

Aquavit’s iMicrotox™ (IMX-001) Study Receives IRB Approval

Las Vegas, NEVADA, August 31, 2017 Aquavit pharmaceuticals announced today that it has received a green light from the IRB, to conduct...

PIRACY ALERT

PIRACY ALERT October 21, 2016 Dear Valued Customers and Partners of Aquavit: RE: Illegal Piracy Activities in Korea and China It has come...

Aquavit Pharmaceuticals Registers AQUAGOLD® Device in Korea

NEW YORK, May 30, 2015 /USA/ — Aquavit Pharmaceuticals Inc. (Aquavit) is pleased to announce that it has officially registered its fluid...

Dr. Mary Lupo Joins Aquavit Pharmaceuticals’ Scientific Advisory Board

New York, NEW YORK, November 4, 2014 Aquavit Pharmaceuticals welcomes Mary Lupo, MD, FAAD as its newest Scientific Advisory Board member....

News: Blog2